Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A polypharmacological network of predicted targets is a computational framework used to identify and visualize the multiple biological molecules—such as receptors, enzymes, and transporters—that a single drug compound is predicted to interact with (Hopkins, 2008, Nature Chemical Biology). This approach moves beyond the traditional one drug, one target model, acknowledging that many therapeutic agents achieve their efficacy through the modulation of multiple pathways simultaneously (Anighoro et al., 2014, Medical Research Reviews). These networks are typically constructed using in silico techniques, including molecular docking, machine learning, and chemogenomic screening, to map the potential binding landscape of a molecule across the proteome (Peters, 2013, Expert Opinion on Drug Discovery). By analyzing these networks, researchers can predict therapeutic outcomes, identify potential off-target toxicities, and explore opportunities for drug repurposing. This systems-level perspective is essential for addressing complex, multifactorial diseases like cancer and neurodegeneration, where single-target interventions may be insufficient.
Not applicable as this is a computational concept rather than a biological molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polypharmacological network of predicted targets (None).